Table 1
The ‘logic’ of schizoaffective disorder applied to anxiety and OCD
Symptom course | ‘Primary’ feature | ‘Secondary’ feature | Diagnosis |
---|---|---|---|
2 weeks of ≥2 psychotic symptoms outside of a major mood episode plus a manic or depressed episode | 2 weeks of psychotic and negative symptoms | 2 weeks of low mood or anhedonia or 1 week of elevated or expansive mood | Schizoaffective disorder |
1 month of social anxiety and avoidance outside of a major mood episode plus a manic or depressed episode | 1 month of social anxiety and avoidance | 2 weeks of low mood or anhedonia or 1 week of elevated or expansive mood | ‘Socio-anxious-affective disorder’* |
1 month of obsessions and compulsions outside of a major mood episode plus a manic or depressed episode | 1 month of obsessions and compulsions | 2 weeks of low mood or anhedonia or 1 week of elevated or expansive mood | ‘Obsessocompulso-affective disorder’* |
OCD: obsessive-compulsive disorder | |||
* These diagnoses are hypothetical disorders used to illustrate how the criteria used to define schizoaffective disorder subsume other types of symptoms |
A continuum approach
As a way out of this inductive logic trap, we suggest the following statements as evidence-based and clinically realistic ways of approaching psychosis assessment.
‘Normal sadness’ and ‘normal psychosis’ are equivalent. The DSM-IV-TR description of major depressive disorder, states that “periods of sadness are inherent aspects of the human experience.”12 However, descriptions of psychosis rarely reflect that psychotic-like experiences are quite common13-19 and easily induced in otherwise healthy people.20 Psychotic symptoms are widely described as being genetically linked to normally distributed personality traits.21-24 Finally, research on risk for developing chronic psychosis has identified that most patients who develop attenuated psychotic symptoms do not experience them chronically.25-28 Together, these data argue strongly for a concept of psychosis as common and continuously distributed across large groups.
A psychosis screen can be much more than ‘+/- AH/VH/PI.’ We reject the idea that psychotic phenomena are fundamentally different from “normal” occurrences such as imagined or inner speech, perceptual fluctuations, distorted or rigid beliefs, or inability to accurately express one’s emotional state. Yet abnormal perception, affect flattening, and delusions often are viewed as “really weird,” which suggests most people never experience these phenomena, only “affected” people. This easily can lead to cognitive errors that associate psychosis as a state of mind that is fundamentally different from non-psychosis. In fact, DSMIV-TR categorizes the presence of persistent psychotic symptoms as evidence of disorder until proven otherwise.3
We feel that this simplistic language describing psychosis as inherently pathological ignores the clinical richness of psychotic experience. In our experience, many individuals who have been diagnosed with chronic psychosis have never been asked:
- about the timing, intensity, and character of their abnormal sensory experiences29
- how their beliefs and schemas affect day-to-day behavior and choices
- if their psychotic symptoms are bothersome or troubling.
We worry that a person experiencing impairing psychotic symptoms could become overshadowed by all-or-none assumptions about the symptoms themselves.
We propose Table 2 as a guideline for approaching psychotic symptoms as expressions along a continuum of experience, one that shares much in common with recent well-developed biopsychosocial models of psychotic phenomena.30 In our view, this allows for a therapeutic alliance that focuses on patient recovery, as opposed to seeing psychotic symptoms as the only treatment targets. By moving beyond all-or-none myths and approaching psychosis as a continuum with normal experience, we believe that patient recovery can become a realistic goal.
Table 2
Revising the clinical language of psychosis to separate presence from pathology
Symptom | Continuum | Attenuated experience | Pathological experience (‘disorder’) | Psychotherapeutic intervention |
---|---|---|---|---|
Paranoid ideation/delusions | Schematization and testing of environmental information |
|
|
|
Hallucination | Higher order sensory processing and self/other discrimination |
|
|
|
Disorganized speech / ‘thought disorder’ | Social pragmatics and conceptual linking |
|
|
|
Source: Bechdolf A, Phillips LJ, Francey SM, et al. Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):159-173. Bentall RP, Fernyhough C. Social predictors of psychotic experiences: specificity and psychological mechanisms. Schizophr Bull. 2008;34(6):1012-1020. French P, Morrison AP. Early detection and cognitive therapy for people at high risk of developing psychosis: a treatment approach. West Sussex, United Kingdom: John Wiley and Sons; 2004. Christodoulides T, Dudley R, Brown S, et al. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series. Psychol Psychother. 2008;81(Pt 2):199-207. Davis LW, Ringer JM, Strasburger AM, et al. Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatr Rehabil J. 2008;32(1):55-58. Jackson HJ, McGorry PD, Killackey E, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: the ACE project. Psychol Med. 2008;38(5):725-735. Lecomte T, Leclerc C, Corbiere M, et al. Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis. 2008;196(12):866-875. Loewy RL, Johnson JK, Cannon TD. Self-report of attenuated psychotic experiences in a college population. Schizophr Res. 2007; 93(1-3):144-151. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-715. Mitchell AJ. CBT for psychosis. Br J Psychiatry. 2004;185:438; author reply 438. Rathod S, Kingdon D, Weiden P, et al. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review. J Psychiatr Pract. 2008;14(1):22-33. Wright JH, Kingdon D, Turkington D, et al. Cognitive-behavior therapy for severe mental illness. Arlington, VA: American Psychiatric Publishing, Inc.; 2008. |